Press release
LAMEA Oncology/Anti-Cancer Drugs Market is Expected to Reach $17.0 Billion, by 2021 segmented into therapeutic modalities, types of cancer, and countries
Oncology/Anti-Cancer Drugs
Get PDF Sample: https://www.alliedmarketresearch.com/request-sample/863
High prevalence and rising incidence rates of major types of cancers (such as breast cancer and prostate cancer), emerging treatment algorithms and widespread use of anti-cancer drugs for treating conditions such as blood cancer (leukemia) is expected to drive this market. In addition, growing popularity of biological and targeted drug therapies, which help in improving the patientssurvival time, are projected to provide opportunities in the LAMEA oncology/anti-cancer drugs market. However, factors such as high cost associated with cancer drugs and related side effects are likely to affect the market growth.
Key findings of LAMEA Oncology/Anti-Cancer Drugs Market:
• Immunotherapy (biologic therapy) is projected to be the fastest growing segment, registering a CAGR of 12.2% during the forecast period.
• Chemotherapy is expected to dominate the LAMEA oncology/cancer drugs market throughout the forecast period.
• Blood cancer segment would lead the LAMEA oncology/cancer drugs market through 2021.
• Algeria is anticipated to be the fastest growing country in the LAMEA oncology/anti-cancer drugs market, registering a CAGR of 12.8% between 2015 and 2021.
• Brazil was the highest revenue generating country in the LAMEA oncology/anti-cancer drugs market with about one third of market share in 2015.
Saudi Arabia, is the leading country market from the Middle East region and would continue to lead until 2020, owing to rising incidence rates of cancer, high healthcare expenditure and gross national income (GNI) in Saudi Arabia. Algeria, is expected to witness highest growth rate because of considerable funding, urbanized healthcare facilities and establishment of national healthcare systems. Furthermore, acquisition is the key growth strategy adopted by the leading players in the market, which helped companies to expand their oncology drugs business. In addition, the market players have also adopted strategies, such as approval and collaborations, to sustain the competition in the market. The key companies profiled in the report include, Amgen Inc., AstraZeneca Plc., Roche Diagnostics, GlaxoSmithKline PLC, Merck & Co., Novartis AG, AbbVie Inc. Sanofi, EIMC United Pharmaceuticals (EUP) and Actavis plc.
Significant Note: Customize Report As per your Requirements: https://www.alliedmarketresearch.com/request-for-customization/863
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
Shriram Dighe
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release LAMEA Oncology/Anti-Cancer Drugs Market is Expected to Reach $17.0 Billion, by 2021 segmented into therapeutic modalities, types of cancer, and countries here
News-ID: 1194998 • Views: …
More Releases from Allied Market Research
3D Printing Filament Market Comprehensive Growth Outlook and Trend Analysis, 202 …
According to the report, the global 3D printing filament market was valued at $0.9 billion in 2023 and is projected to reach $2.3 billion by 2031, registering a CAGR of 12.8% from 2024 to 2031.
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/3d-printing-filament-market-A11572
Key Growth Drivers:
The growth of the 3D printing filament market is fueled by continuous advancements in filament materials-such as carbon fiber-reinforced composites, metal-infused filaments, and high-performance engineering plastics. These innovations…
Wet Chemicals Market Detailed Analysis, Growth Trends, and Future Outlook 2025-2 …
According to a recent report by Allied Market Research (AMR), the global wet chemicals market is poised for substantial growth, projected to reach a value of $5.9 billion by 2031, up from $3.2 billion in 2021. This comprehensive analysis explores market dynamics, growth drivers, and strategic initiatives while highlighting key opportunities across regions and industry segments.
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A17425
The study delves into development trends, investment frameworks, and…
Nonwoven Fabrics Market Outlook to 2033 Projected High CAGR and Growth Opportuni …
A new report titled "Nonwoven Fabrics Market by Polymer Type (Polypropylene (PP), Polyethylene (PE), Polyethylene Terephthalate (PET), Wood Pulp, Rayon, and Others), Function (Disposables and Durables), Technology (Spunbond, Dry Laid, Air Laid, Wet Laid, Meltblown, and Others), and Application (Hygiene, Wipes, Medical, Filtration, Automotive, Building & Construction, and Others): Global Opportunity Analysis and Industry Forecast, 2024-2033" has been released by Allied Market Research.
Key Highlights:
- Market Size (2023): $58.4 Billion
- Projected…
Utilities Asset Management Market Poised for 11.3% CAGR Growth, Key Players, Mar …
According to the report published by Allied Market Research, the global utilities asset management market generated $4.3 billion in 2021, and is projected to reach $12.4 billion by 2031, growing at a CAGR of 11.3% from 2022 to 2031.
The report offers a detailed analysis of the top winning strategies, evolving market trends, market size and estimations, value chain, key investment pockets, drivers & opportunities, competitive landscape and regional landscape.…
More Releases for LAMEA
LAMEA Beer Market Size Analysis by Application, Type, and Region: Forecast to LA …
USA, New Jersey- According to Market Research Intellect, the global LAMEA Beer market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The expansion of contemporary retail channels, urbanization, and changing consumer preferences are all contributing factors to the LAMEA beer market's steady but slow growth. Beer…
LAMEA Wine Market 2023 Driving Factors Forecast Research 2029
LAMEA wine market is estimated to grow at a CAGR of 3.5% during the forecast period. In 2018, the market in LAMEA was valued at $17.3 billion and is further estimated to reach $21.9 billion in 2025. The factors contributing to the market growth include increasing demand for alcoholic beverages in emerging economies such as Brazil and South Africa due to their growing population base and increasing consumption of alcohol…
LAMEA IVD Market | Business Development Strategies
LAMEA IVD market size was valued at $7,413 million in 2016, and is projected to reach at $10,316 million by 2023, growing at a CAGR of 4.7% from 2017 to 2023. The immunodiagnostics segment accounted for more than two-ninths share of the total market in 2016.
Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/4137
In vitro diagnostics (IVD) are medical devices and reagents used for examination of the body samples such as blood, tissue, and…
LAMEA Carbon Fiber Market Research and Forecast 2020-2026
The LAMEA carbon fiber market is estimated to grow significantly during the forecast period. The market growth is attributed to the significant presence of major end-user industries of carbon fiber in the region. According to SIPRI, Saudi Arabia had a military expenditure of nearly $63.7 billion, $70.4 billion, and $67.6 billion in 2016, 2017, and 2018, respectively. Moreover, the military expenditure of Israel and Iran was $15.9 billion and $13.2…
LAMEA Aerospace Carbon Fiber Market Research and Forecast 2020-2026
LAMEA aerospace carbon fiber market is estimated to grow significantly during the forecast period owing to the growing aerospace industry. As per the Aerospace Industries Association of Brazil in 2017, with around 100 facilities for aircraft manufacturing, the state accounts for 73.0% of Brazil units. The Brazilian aerospace industry is the largest and the most vital in the Southern Hemisphere. Brazil has been among the top 10 export destinations for…
LAMEA Tea Bag Market Trends, Size, Forecast - 2019-2025
LAMEA tea bag market is estimated to grow at a CAGR of 6.0% during the forecast period. Brazil is considered as one of the countries with a significant consumption and production of coffee and tea in Latin America. With the growing health and wellness concerns, the Brazilian consumers' decisions to buy tea are based on their antioxidant and other beneficial properties, which in turn, is likely to increase consumption of…
